Possible associations among expression of p14ARF, p16INK4a, p21WAF1/CIP1, p27KIP1, and p53 accumulation and the balance of apoptosis and cell proliferation in ovarian carcinomas

Cancer

Volumn 92, Issue 5, 2001, Pages 1177-1189

  Saegusa, Makoto ^a   Machida, Daisuke ^a   Okayasu, Isao ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Cell proliferation; Cyclin dependent kinase inhibitor; Ovarian carcinoma

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; MESSENGER RNA; PROTEIN P14; PROTEIN P16; PROTEIN P21; PROTEIN P27; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLEAR CELL CARCINOMA; CONTROLLED STUDY; FEMALE; GENE CONTROL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MITOSIS INDEX; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; RNA ANALYSIS; WESTERN BLOTTING;

ADULT; AGED; APOPTOSIS; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MITOTIC INDEX; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0035446818     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010901)92:5<1177::AID-CNCR1436>3.0.CO;2-5     Document Type: Article

References (43)

1. K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary
2. Alteration of the p53 tumor suppressor gene occurs more frequently serous adenocarcinomas than other common epithelial tumors of the human ovary
3. Frequent allelic losses and mutations of the p53 gene in human ovarian cancer
4. Frequent microsatellite instability in epithelial borderline ovarian tumors
5. Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen
6. G1 phase progression: Cycling on cue
7. Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age
8. Inhibitors of mammalian G1 cyclin-dependent kinases
9. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function
10. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6
11. ink4
12. p21 is a universal inhibitor of cyclin kinases
13. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21
14. Cloning of p57 Kip2, a cyclin-dependent ent kinase inhibitor with unique domain structure and tissue distribution
15. INK4 in human ovarian tumours
16. Clear cell carcinoma has an expression pattern of cell cycle regulatory molecules that is unique among ovarian adenocarcinomas
17. Lack of independent prognostic significance of p21 and p27 expression in advanced ovarian cancer: An immunohistochemical study
18. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression
19. INK4/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage
20. INK4A in archival human solid tumors: Correlation with retinoblastoma protein expression
21. Apoptosis: Its significance in cancer and cancer therapy
22. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms
23. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
24. Bcl-2 expression is correlated with a low apoptotic index and associated with progesterone receptor immunoreactivity in endometrial carcinomas
25. Apoptosis, cell proliferation and expression of Bcl-2 and Bax in gastric carcinomas: Immunohistochemical and clinicopathological study
26. Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis
27. Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma
28. Alteration of p16 and p15 genes in common epithelial ovarian tumors
29. INK4 in ovarian cancer is associated with progression and unfavourable prognosis
30. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence
31. Rb and p16INK4a expression in resected non-small cell lung tumors
32. INK4a genes in human esophageal squamous cell carcinoma
33. INK4a methylation and p53 mutational status
34. Functional and physical interactions of the ARF tumor suppressor with p53 and MDM2
35. The alternative product from the human CDKN2a locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2
36. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21
37. Waf1/Cip1 sensitizes tumors to radiation by an apoptosis-independent mechanism
38. Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human breast carcinoma cells by prostaglandin A2
39. p21 (Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells
40. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
41. Promoting apoptosis: A novel activity associated with the cyclin-dependent kinase inhibitor p27
42. Apoptotic index in ovarian carcinoma: Correlation with clinicopathologic factors and prognosis
43. WAF1/CIP1 is heterogeneous and unrelated to proliferation index in human ovarian carcinoma